BioSpace News Archive

Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector

Adcomms

Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm

After getting slapped with a surprise refuse-to-file letter signed by former CBER Director Vinay Prasad, Moderna’s flu vaccine application will now go before the FDA’s Vaccine advisory committee.

May 22, 2026

·

2 min read

·

Tristan Manalac

Electricity saving, ecology awareness or reduce electric cost and expense concept, man pulling electric cord to unplug to save money or for ecology power.

Parkinson’s disease

Biogen, Denali pull plug on Parkinson’s program after mid-stage flop

Biogen and Denali’s Parkinson’s disease drug failed to significantly slow disease progression in a Phase 2b study, missing both primary and secondary endpoints.

May 22, 2026

·

2 min read

·

Tristan Manalac

High Quality background with Two Flags of South Korea and USA

Manufacturing

Gilead inks $140M API supply deal, tightening ties to Korean manufacturer

The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan.

May 22, 2026

·

1 min read

·

Nick Paul Taylor

Lung organ anatomy symbol for health and medical illustrations. vector, illustration.

Antibody-drug conjugate (ADC)

Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival

Treatment with the TROP2 ADC sac-TMT led to a 70% objective response rate and progression-free survival was “significantly improved” as compared to placebo—the second positive readout for the asset this week.

May 22, 2026

·

3 min read

·

Annalee Armstrong

Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out

Funding

Recordati fields $12.4B go-private offer

Going private could give Recordati strategic flexibility and a stable source of capital, according to CVC Capital Partners and Groupe Bruxelles Lambert, which are offering to take the Italian pharma private for a 13% premium.

May 22, 2026

·

2 min read

·

Tristan Manalac

Press Releases

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - May 21, 2026

May 22, 2026

·

1 min read

Press Releases

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development